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The current goal in treating an acute ischemic stroke
is to reopen the occluded vessels for regional reperfu-
sion and salvage of threatened tissues. An intravenous
administration of recombinant tissue plasminogen
activator (rt-PA) was established to improve effectively
neurological  outcomes  after  an  acute  stroke.
Unfortunately, intravenous thrombolysis is available
within a period of fewer than 3 or 4.5 hours, or has
contraindications, such as recent surgery. Another
disadvantage of intravenous thrombolysis is that the
recanalization rate is less than 50% [1]. The Pro-
Urokinase for Acute Cerebral Thromboembolism II
(PROACT-II) trial randomized patients to either an
intra-arterial delivery of recombinant pro-urokinase or
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Purpose: In recent years, mechanical thrombectomy using Solitaire stent retrieval has been tried for
treating acute ischemic stroke with a large artery occlusion. We systematically reviewed published
articles to appraise the evidence that supports the safety and efficacy of the mechanical thrombec-
tomy in acute strokes with Solitaire stent.  
Materials and Methods: Systematic searches using Medline and Scopus were performed for studies eval-
uating mechanical thrombectomy using a Solitaire stent in acute ischemic stroke. Articles were
included if they were published since 2008, contained at least 5 subjects, and provided clinical
results. 
Results: Thirteen articles (262 cases) were included in this review. The mean time of the procedures
ranged from 37 to 95.6 minutes in 10 studies. The success of recanalization was achieved in 89.7%
and the recanalization rate varied from 66.7% to 100% in all 13 studies. The overall rates of the
symptomatic hemorrhagic complications and mortality were 6.8% and 11.1%, respectively. A favor-
able outcome of mRS 2 or under was 47.3%. Procedure-induced complications developed in 3.4%. 
Conclusion: The present review suggested that mechanical thrombectomy using a Solitaire stent in acute
ischemic stroke was effective in recanalizing the occluded artery. The rate of procedural complica-
tions was small.
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demonstrated that intra-arterial thrombolysis could
offer benefits when applied to all patients with acute
ischemic stroke [2]. Intra-arterial thrombolysis
provides several advantages over the intravenous route
by allowing a direct infusion of the thrombolytic agent
into the thrombus, a longer time window of administra-
tion, and a higher recanalization rate. However, brain
hemorrhage related to an administrated fibrinolytic
agent can worsen the outcome of patients. Today, the
achievement of recanalizing an occluded artery is a
persistent challenge in the neurointerventional field.
Much work has been focused on the endovascular
mechanical thrombectomy because of its advantages
over pharmacologic thrombolysis, including a rapid
achievement of recanalization and enhanced efficacy in
hemorrhagic events. 
Since intra-arterial thrombolysis were proven by
PROACT II trials in 1999, there has been many efforts
to recanalize the occluded artery by endovascular
methods, and novel devices that can easily approach
intracranial arteries has leaded the use of devices for
the thrombectomy of occluded intracranial arteries.
Recently, the U.S. Food and Drug Administration
(FDA) approved 2 neurothrombectomy devices as a
endovascular device for restoring blood flow in
patients experiencing an acute stroke who are
otherwise ineligible for intravenous rt-PA, or for whom
intravenous rt-PA has failed: the MERCI Retriever
�
(Concentric Medical, Mountain View, CA, U.S.A.) and
the Penumbra System (Penumbra, Alameda, CA,
U.S.A.). Several prospective clinical trials have
supported the benefits and safety of these devices.
Apart from these two devices, various techniques with
off-label devices, including balloon angioplasty,
thrombus fragmentation, aspiration, and thrombectomy
have been reported to recanalize large arteries.
Especially, there is a growing concern for the use of the
stent in recanalizing the occluded artery. One of the
recanalization techniques with the stent is the
thrombectomy by retrieval of a self-expanding stent.
The Solitaire neurovascular remodeling device (ev3
Inc, Irvine, CA, U.S.A.) that received the CE mark for
the treatment of neurovascular diseases in 2007 was
initially designed for aneurysm neck remodeling. This
stent has a characterization that is fully retrievable and
can be applied repeatedly. Thus, this stent can be used
as a temporary recanalization with an enhancing effect
of thrombolytic agent or it can pull the thrombus
captured between the strut out of the body. The merit of
the stent retrieval is that it can be applied repeatedly, it
is accessible to small arteries, and there is no need for
anticoagulation therapy. Unfortunately, despite several
reports that have presented the application of the
Solitaire stent to thrombectomy in acute stroke, there is
scant evidence to back this up. Therefore, a critical
evaluation of the current evidence is needed to assess
the safety and efficacy of the mechanical thrombec-
tomy using the Solitaire stent retrieval. 
The objective of this review was to appraise the
evidence that supports the safety and efficacy of the
mechanical thrombectomy using a Solitaire stent
retrieval in acute stroke.
MATERIALS AND METHODS
The principal goals were to review the clinical
results, safety, and technical aspects regarding mechan-
ical thrombectomy in the treatment of ischemic stroke
using Solitaire stent retrieval. Our primary search
began with a review of English language citations since
2008 using Medline and Scopus. The free-text search
terms, “stroke”, “infarction”, “mechanical thrombec-
tomy”, “Solitaire”, “mechanical recanalization”, “clot
retrieval”, “stent recanalization”, and “retrievable
stent” were used in combination with Boolean
operators AND or OR. Two reviewers independently
screened titles and abstracts to identify potentially
relevant articles. We included studies of any research
design, such as case series, prospective trials, and
retrospective observations, all of which contained at
least 5 subjects and a specified reporting system of
clinical results (i.e., Recanalization and modified
Rankins score (mRS)). Studies that included not only
thrombectomy using Solitaire stent retrieval but also
other recanalization methods were included if the data
were reported separately for each intervention. The
studies were limited to those conducted on human
subjects. Studies that reported a Solitaire stent was not
used with the aim of arterial recanalization in treating
acute stroke, use of another clot retrieval device, or
review articles were excluded. When multiple articles
drew on the same datasets, data were abstracted only
once from the most comprehensive available report. 
Data were collected for each study, including raw
numbers plus any summary measures with standard
deviations or ranges. Using a predesigned data extrac-
tion form, data extraction was performed based on the
following: patient characteristics (sample size, age, sex,
National Institutes of Health Stroke Scale (NIHSS)
before procedure, affected artery, the presence of a
tandem lesion); inclusion criteria for mechanical
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Jun Seok Koh, et al.thrombectomy (time window, radiologic screening tool,
time criteria for intravenous rt-PA); time-related data
(time from stroke symptom onset to beginning of
intervention (TI), procedural time, and time from
symptom to the ending of procedure (TR)); technical
information (whether balloon-mounted guiding
catheter was used for flow arrest, concurrent
intravenous thrombolysis, concurrent with other
endovascular interventions, passing time of stent); and
outcome variables (recanalization rate, symptomatic
hemorrhage, procedure related complications, mortality
within 3 months, and functional outcome).
The affected artery was classified as middle cerebral
artery (MCA), terminal carotid artery (T-carotid) and
vertebrobasilar artery. Recanalization was considered
achieved when Thrombolysis in Myocardial Ischemia
scale grade (TIMI) was 2 to 3 or when Thrombolysis in
Cerebral Infarction grade (TICI) was 2b to 3. Technical
failure was defined as an inability to access the clot
with the device used. After endovascular intervention,
the functional outcome was rated by using NIHSS and
mRS. When available, mRS status 3 months post-
stroke was used. A good outcome was defined as mRS
2 and less, or the NIHSS score had decreased by 10
points or more compared with pre-interventional
NIHSS.
RESULTS
Selection processing
An initial search identified 634 abstracts. Next, 76
articles reporting information about mechanical
thrombectomy using the Solitaire stent retrieval in the
treatment of acute stroke were retrieved for further
screening. Twenty articles were identified as possible
candidates for evaluation, of which 7 were excluded for
the following reasons: data overlapped with data in the
other articles [3-5], insufficient data or case numbers
[6-8], and an animal study [9]. The remaining 13
studies [3, 4, 10-21] were included for this review.
There were no published randomized controlled trials
of Solitaire thrombectomy compared to intravenous
thrombolysis or other endovascular procedures. Two
were retrospective comparative studies [10, 15], 2 were
prospective case series [12, 19], and the rest were
retrospective case series. The total number of patients
included in this review was 262. Seven studies [3, 11,
13, 14, 17, 18, 21] presented individual raw data. The
remaining 6 studies [4, 10, 12, 15, 19, 20] presented
data as means or medians. Quantitative pooled meta-
analysis was not performed due to heterogeneity of the
study designs, inclusion criteria, and patient population. 
Patients’ characteristics and Indication criteria for
recanalization (Table 1)
The mean age of patients varied from 58.9 to 76.4
years in the 13 studies. Of the 236 patients in 12
studies, there were 113 females. Mean initial NIHSS
ranged from 14 to 21.4. Occluded segment included
149 MCAs (56.9%), 59 T-carotids (22.5%), and 54
vertebrobasilar arteries (20.6%). Forty-one cases of 192
MCA or T-carotid occlusions (21.60%) from 11 studies
had tandem stenosis of proximal carotid artery. 
Eleven studies identified the indications for recanal-
ization therapy. However, the criteria were different for
each study. The time window for anterior circulation
ranged from 4.5 to 8 hours and posterior circulation
was 24 hours. All studies used intravenous thromboly-
sis on the patients within 4.5 hours except for 1 case
series that enrolled only patients with contraindication
to intravenous thrombolysis. CT and/or MRI were used
to evaluate the salvaging brain tissues and the presence
of hemorrhage. NIHSS scores for the inclusion criteria
varied from 4 to 12. 
Time and Technical data (Table 2)
TI was identified in 9 studies: the mean TI varied
from 160 to 462.5 minutes. The mean time of the
procedures ranged from 37 to 95.6 minutes in 10
studies, and the mean time for 8 of which were under
60 minutes. TR was 233 to 588 minutes in 10 studies. 
Balloon-mounted guiding catheters were used in the
anterior circulation for 6 of the 12 studies, but 6 studies
were operated without balloon protection. Concurrent
performance of intravenous thrombolysis was recorded
in all 13 studies. One study had enrolled patients who
were treated with only intra-arterial thrombectomy due
to a contraindication of intravenous rt-PA. Bridging
thrombolytic therapy combined with intravenous rt-PA
or endovascular procedure for occlusions intractable to
rt-PA were performed on 119 of 262 patients (45.4%).
Concurrent endovascular interventions, such as intra-
arterial thrombolysis, suction thrombectomy with
Penumbra, and detachment of stent or balloon
angioplasty before and after Solitaire thrombectomy,
were attempted in 56 cases (21%). Nine studies identi-
fied the passing time of the Solitaire stent. Passing time
varied from 1 to 7, and the mean passage rate ranged
from 1.4 to 2.5.
Angiographic and Clinical results (Table 3)
The success of recanalization was achieved in 235
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 cases (89.7%) and the recanalization rate varied from
66.7% to 100% in all 13 studies. The reporting of
NIHSS after procedure was identified in 10 studies.
The time to record the post-procedural NIHSS varied
from immediate to 3 months. 102 of 196 subjects
(52.0%) in 10 studies received a good outcome NIHSS
rating. Symptomatic hemorrhagic complications
developed in 16 out of 236 cases (6.8%) in 12 studies.
The overall mortality rate was 11.1% (29/262). In all
studies except for 1 series, which achieved mRS at 1
month, mRS was assessed at 3 months after the
procedure. The overall rate of a favorable mRS
outcome was 50.8% (133/262). Procedure-induced
complications included 5 subarachnoid hemorrhages, 2
self-detachments of stent, 1 entanglement of stent, and
1 in-stent thrombosis.   
DISCUSSION
This systematic review analyzed the studies had
enrolled patients who were treated with mechanical
thrombectomy using Solitaire stent retrieval for acute
ischemic stroke, after being ineligible to receive
intravenous rt-PA therapy or for which intravenous rt-
PA therapy had failed or be bridged with intravenous
rt-PA. The present review demonstrated that mechani-
cal thrombectomy with Solitaire stent retrieval
provided a high recanalization rate and low procedure-
related complications. Favorable functional outcome
was achieved in approximately half of the subjects. 
The most of self-expanding stent for intracranial
artery was originally designed as a supporting device in
aneurysm coiling procedures. In 2006, an off-label use
of the stent in acute stroke recanalization was discussed
for the first time [22]. Initially, the self-expanding stent
had been used in permanently deployment at occluded
artery for recanalization. The concept of a stent
placement was to entrap the thrombus between the
stent and the vessel wall to restore antegrade blood
flow by creating a channel inside the thrombus [23,
24]. This may be followed by thrombus dissolution via
either endogenous or pharmacologic thrombolysis.
However, permanent stent implantation requires a
subsequent antiplatelet agent with an increased risk of
intracranial hemorrhage. Another concern is the risk of
in-stent stenosis. Despite limited data, several
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Table 2. Time and Technique Data
Time, Minutes Techniques
Author, year TI, mean Procedure time,  TR, mean Balloon  IVT,  Concurrent  Pass, 
(range) mean (range) (range) protection n intervention, n mean (range)
Nayak S
17, 2010  160±83.1 84.3±33.0 307.1±106.7 No 6 9 1.9±1
Castano C
11, 2010  312.7±125.5 57.9±26.0 370.7±139.1 Yes 7 0 …
Roth C
19, 2010  …… 277±118 No 13 10 1.77 (1~4)
Cohen JE
3, 2012  254.1±104.5 45.2±15.3 299.3±113.7 Yes 11 0 2.3±1.2
Stampfl S
20, 2011  240.9±71.4 48.3±21.9 377 (178~970) No 5 4 2.5±1.9
Brekenfeld C
10, 2011 … m52.5 (37.5~61) … Yes 6 13 1.35 (1~3)
Mohlenbruch M
15, 2011E  183 (128~ 397) 54 233 No 13 1 2 (1~7)
Park H
18, 2011  197.1±95.0 40.9±15.1 238±106.1 Yes 4 1 1.5±0.8
Machi P
12, 2011  316   37  353 Yes 17 0 2 (1-5)
Mpotsaris A
16, 2011  …… 328.6±149.2 … 19 0 …
Wehrschuetz M
21, 2011  339.1±109.2 …… No 11 0 2.3±1
Menon BK
13, 2012  … 84 (26~164)* (n=12) … No 7 13 1~5
Miteff F
14, 2011  462.5±582.8 95.6±41.0 558.2±577.8 Yes 0 4 …
Summary  160~462.5 (9) 37~95.6 (10) 233~588 (10) Yes: 6,  119/262,  55/262,  1.4~2.5 (10)
(The number of articles) No: 6 45.4% 55%
Abbreviations: TI, time from stroke symptom onset to beginning of intervention; TR, time from symptom to the ending of procedure; SD,
standard deviation; IVT, intravenous thrombolysis
*Procedure time was not recorded in 2 patients. retrospective  case  series  have  demonstrated
thromboembolic complications and fatal intra-cerebral
hemorrhage [25, 26]. The next technique using a stent
in treatment for acute stroke was the temporary
endovascular bypass. A partial deployment of a self-
expandable stent (Enterprise stent, Codman, Raynham,
MA, U.S.A.) has resulted in an immediate recanaliza-
tion of occluded cerebral artery that was refractory to
intravenous or intra-arterial fibrolytic agents [27, 28].
This technique had the advantage of avoiding
antiplatelet therapy or in-stent stenosis, compared with
the permanent implant of the stent. The last presented
technique using a self-expanded stent is the retrieval of
the stent, which allows for the temporary recanalization
as well as the extraction of the thrombus from cerebral
circulation. 
There have been several reports about Solitaire
thrombectomy since the first case was reported in 2009
[29]. The Solitaire is a self-expanding stent initially
designed for bridging the neck of aneurysms that is
retrievable even after complete deployment for adjust-
ment and superior placement, if not detached. Its open-
slit, closed-cell design gives an optimal radial force
with good kink resistance and maximizes the opportu-
nity for trapping the clot [30]. These properties have
led to its use in acute stoke, in which the thrombus
within the cerebral vessels is trapped within the struts
of the stent and pulled out of the body. Because the
Solitaire stent was designed for neck remodeling of
aneurysm coiling, the delivery and deployment of this
stent can be handled easily by a single operator, and the
Solitaire can be delivered through a standard 0.021 or
0.027 inch (internal diameter) microcatheter. The use
of a microcatheter for the delivery of the Solitaire stent
allows easier navigation and safer manipulation
because of its flexibility, and may reduce the chance of
a thrombolysis failure in difficult cases, such as elderly
patients with tortuous vessels. The merit of the Solitaire
stent is that its simplicity of approach to the intracranial
artery may make thrombolytic procedures easier.
Compared with the MERCI (2.4 Fr) and Penumbra
systems (varied from 2.8 Fr to 4.1 Fr), the Solitaire
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Table 3. Angiographic and Clinical Results
Recanalization,  Follow-up NIHSS Symptomatic  Good  Mortality,  Procedure-
Author, year  n (rate) mean;  ICH,  functional  n induced 
Good results, n;  n   results complication
Measuring time (mRS≤2), n
Nayak S
17, 2010  7 (100%) 12±4.9; 3/7; immediate 1/7 4/7 1/7 *1 Self-detach
Castano C
11, 2010 15 (100%) 6.3±6.0; 7/14; 7days 1/15 8/15 4/15 1 SAH
Roth C
19, 2010  20 (90.9%) NA; 14/22; discharge  2/22 11 /22 4/22
Cohen JE
3, 2012  17 (100%) 5.1±3.2; 15/16; 7days 2/17 15/17 1/17
Stampfl S
20, 2011  12 (66.7%) NA 3/18 6/18 3/18
Brekenfeld C
10, 2011 16 (94.1%) m14 (6-20); NA; 1day 0/17 7/17 0/17
Mohlenbruch M
15, 2011E  22 (88%) 4 (2-9); NA; 7days 3/25 15/25 2/25
Park H
18, 2011  8 (100%) 12.3±7.7; 1/8; immediate  0/8 4/8 0/8
Machi P
12, 2011  50 (89.3%) NA; 30/56; discharge 1/56 26/56 4/56 2 SAH
Mpotsaris A
16, 2011  23 (88.5%) 7.4±6.4; 11/26; discharge … 10/26 2/26
Wehrschuetz M
21, 2011  8 (72.7%) 10±7; 2/11; immediate 0/11 8/11 1/11
Menon BK
13, 2012 12 (70.6%) 8.8±7.9; 3/12; 1day 1/14 8/14 2/14 1 In-stent thrombosis, 1 SAH
Miteff F
14, 2011  25 (96.2%) NA; 16/20; 3months 2/26 11/26 5/26 1 Self-detach,
�1 entanglement, 1 SAH
Summary  235/262,  102/196,  16/236,  133/262,  29/262, 
(the number of articles) 89.7% 52.0% (10) 6.8% (12) 47.7%  11.1%
Abbreviations: ICH, intracerebral hemorrhage; SAH, subarachnoid hemorrhage; NA, not applicable 
*Self-detach means an unanticipated self-detach of stent during procedure
�Entanglement means the entanglement of stent during procedurestent can be delivered by the microcatheter with the
smallest  distal  outer  diameter  (Rebar
TM 18
microcatheter, ev3; 2.3 Fr). 
Theoretically, another advantage of the Solitaire stent
is recanalization time-saving. In a study that compared
the clot retrieval with Solitaire stent and other endovas-
cular procedures, including mechanical thrombectomy
and intra-arterial thrombolysis [10], the advantage of
the Solitaire thrombectomy device was in reducing the
time to recanalization in a multimodal approach to
endovascular stroke treatment. In our review, 8 of the
10 studies have revealed that the mean time of the total
procedure was less than 60 minutes. 
Intravenous rt-PA is the quickest way to initiate
thrombolysis for acute ischemic stroke. However,
thrombus within large vessel is relatively resistant to rt-
PA and IV thrombolysis alone does not result in rapid
recanalization [1, 2, 31]. Compared with intravenous rt-
PA, intra-arterial endovascular therapy has several
theoretic advantages, including site specificity, longer
treatment windows, and higher recanalization rates.
However, the disadvantage of endovascular therapy is
the lag time during which the procedure is initiated. To
avoid low recanalization rates by intravenous rt-PA or
delayed reopening by endovascular procedure, a
bridging approach of both methods has been tried to
enhance a favorable clinical outcome. 
Intra-arterial thrombolysis permits a smaller dose of
fibrinolytic agent to reach a higher local concentration
than intravenous administration and ideally allows
more complete recanalization with lower doses of
thrombolytic. This method’s chief disadvantage,
however, is the lag time during which fibrinolysis is
initiated and proceeded. The mean procedure duration
was 2.1 hours in the PROACT II trials. Particularly in
patients with long-segment artery occlusion, vessel
recanalization with intra-arterial thrombolysis alone is
often unsuccessful in spite of the larger volume of
fibrinolytic agent. Moreover, the recanalization rate
was inferior to that of mechanical thrombectomy.
Therefore, an endovascular approach for acute stroke is
shifting from intra-arterial thrombolysis to mechanical
thrombectomy. 
The best way to treat an acute ischemic stroke is to
remove the occluding thrombi by using an aspiration or
capture of the thrombi before the brain tissues are
damaged by ischemia. In contrast, pharmacologic
fibrinolysis is a long procedure and is often ineffective.
Because these theoretical and practical benefits of
mechanical thrombolysis override the limitations with
pharmacological thrombolysis, various mechanical
devices have been introduced, including wires, coils,
balloons, and capture or aspiration devices. 
Despite a strong demand for mechanical thrombectomy
based on theoretical assumption, there was a little
evidence that legitimizes the use of various devices for
endovascular thrombectomy. At present, only two
devices were approved by FDA. The MERCI retrievers
are a family of corkscrew-shaped products designed to
remove blood clots from the cerebral arteries. The most
recent data of the Multi-MERCI trial, a study with
approximately the same inclusion criteria as the
previous study but with treatment within 8 hours, was
released [32]. One hundred and sixty-four patients were
enrolled, and 131 were initially treated with the newer
generation of MERCI L5 retriever. Recanalization by
pure mechanical thrombectomy was 57.3%, whereas a
recanalization rate of 68% was achieved after
additional  intra-arterial  thrombolysis.  More
importantly, the clinical outcomes after 3 months were
significantly improved. Mean procedure time for
recanalization of MCA occlusion was approxi-
mately100 minutes [33]. The Penumbra system that is
designed for continuous aspiration thrombectomy for
large arterial occlusion is only an aspiration device
indicated for revascularization in acute ischemic stroke.
The Penumbra Pivotal Stroke Trial [34] was a prospec-
tive, multicenter, single-arm study that assessed the
safety and efficacy of the penumbra system with the
largest number of subjects [34]. 81.6% of the treated
vessels were successfully recanalized. 14 patients
(11.2%) were found to have symptomatic intracranial
hemorrhage and all cause mortality was 32.8% within
90 days. A quarter of the patients achieved a favorable
functional outcome. 
In present study, the recanalization rate of the
Solitaire stent (89.7%) was superior to the recanaliza-
tion rate in the Penumbra Pivotal Stroke trial (81.6%)
and the Multi-MERCI trial (69.5%). In the Multi-
MERCI trial, the rate of symptomatic cerebral
hemorrhage, mortality, and favorable outcome were
10%, 34%, and 36% respectively. The Penumbra Pivot
trial revealed that the rate of symptomatic cerebral
hemorrhage, mortality, and favorable outcome were
11.2%, 32.8%, and 20% respectively. When the results
of our review were compared with the results of
Penumbra and MERCI trials, Solitaire stent appeared
to have more favorable clinical outcomes. However,
the present study has been limited by the inclusion of
studies with the suboptimal mythological quality,
heterogeneous cohort, and nonrandomized data.
Therefore, our results should not be compared with
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Currently available neurothrombectomy devices offer
intriguing treatment options in patients with acute
ischemic stroke, although a paucity of high-quality
research exists. Besides MERCI and Penumbra
devices, many articles have reported the use and results
of off-label devices, including snare, laser devices, clot
emulsification system with ultrasound, and thromboap-
siration devices, for acute ischemic stroke. However,
the clinical application is limited because of weak
evidence in these studies. The last review that
summarize the neurothrombectomy devices for the
treatment of acute stroke showed that almost all studies
using off-label devices had small cohorts of under 60
[35].
The first clinical trial to assess the Solitaire stent was
the ReFlow study that investigated whether the applica-
tion of Solitaire stent retrieval is a safe and feasible
method for interventional recanalization of large
vessels with favorable patient outcomes in acute stroke
therapy, and this research has been completed [19].
Currently, 4 ongoing studies evaluating the Solitaire
stent in acute stroke are listed in Clinicaltrial.gov.
STAR (Solitaire FR Thrombectomy for Acute
Revascularisation, NCT01327989) is a prospective
cohort design, and will evaluate the safety and efficacy
of the Solitaire device in subjects requiring mechanical
thrombectomy. Of note, the SWIFT (Solitaire FR with
the Intention for Thrombectomy, NCT01054560) study
will be the first to evaluate the comparative effective-
ness of 2 different technologies, the Solitaire FR and
the MERCI Retriever, by using a prospective, random-
ized method in patients with acute ischemic stroke.
EXTEND-IA (Extending the Time for Thrombolysis in
Emergency Neurological Deficits - Intra-Arterial,
NCT01492725) is a prospective, randomized, open-
label, blinded endpoint design, and has two arms: an
intravenous rt-PA with Solitaire thrombectomy and a
standard intravenous rt-PA. The THRACE (Trial and
Cost Effectiveness Evaluation of Intra-arterial
Thrombectomy  in  Acute  Ischemic  Stroke,
NCT01062698) study will compare intravenous
thrombolysis with thrombectomy procedures using the
MERCI retriever, Penumbra thromboaspiration system,
Catch device, and the Solitaire on approximately 480
patients.
A couple of limitations of our analysis should be
noted. As referred to earlier, this reviewed studies
lacked in well-designed research. Our systematic
review included only retrospective case series and case
series with nonrandomized data. These studies are
likely to have significant publication bias because
negative findings are frequently not published. The
other disadvantage is that the subjects were heteroge-
neous in cohort and reporting methods. Thrombo-
embolic complication, one of the critical complications
during endovascular procedures, was not commented in
almost all the articles. Nevertheless, the merit of this
systematic review is that the findings of emerging data
can help guide clinicians in choosing the most
appropriate treatment for acute ischemic stroke, as well
as encourage more rigorous prospective study designs
with large cohorts in the future.
In summary, we have demonstrated that, overall,
mechanical thrombectomy using a Solitaire stent in
acute ischemic stroke was effective in recanalizing
occluded arteries, and this was not inferior to other
neurothrombectomy devices or pharmacologic fibrinol-
ysis in clinical results. Future studies should attempt to
assess larger and randomized cohorts, and design
prospective and case-controlled studies. 
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